Harvard Team Unveils FIND Drug Screening Platform
Researchers at Harvard and Boston Children's Hospital developed a high-throughput method that identifies molecules by how they alter protein interactions.
Boston Biotech News
For readers in Boston, this page covers gene editing, drug development, genomics research, initial public offerings and industry acquisitions. It follows the intersection of biology and technology throughout the city and surrounding areas.
Recent news
November 5, 2026
Harvard Conference Explores AI in Quantitative GenomicsExperts gathered at Harvard Medical School to discuss using artificial intelligence to combine genomic and clinical data for disease prediction.
November 3, 2026
ARCHIMED Completes Acquisition of Microfluidics UnitThe former Standard BioTools microfluidics business now operates independently as Biomark Scientific.
October 31, 2026
Nanoscope Therapeutics to Attend Boston Tech ConferenceExecutives will present on gene therapy developments at the Advanced Therapies USA 2026 meeting this November.
October 30, 2026
Vor Bio Reports Third-Quarter 2026 Financial ResultsThe Boston-based firm confirms it has completed patient enrollment for its Phase 3 clinical trial in myasthenia gravis.
October 27, 2026
Vin Singh Delivers Keynote at Boston AI SummitThe BullFrog AI founder will discuss the evolution of artificial intelligence in pharmaceutical research.
October 27, 2026
Adagene Executives to Attend Biotech Conference in BostonThe company will participate in the Guggenheim Securities 3rd Annual Healthcare Innovation Conference this November.
October 27, 2026
AI Proteins Partners With Astellas on Drug DiscoveryBoston-based AI Proteins will leverage its platform to design novel miniproteins for Astellas Pharma.
October 27, 2026
Pathos AI Secures Oncology Drug Licensing DealsThe Boston-based biotech firm finalized agreements on August 3, 2026, targeting potential milestone payments of $2.3 billion.
October 26, 2026
Daré Bioscience to Present Implantable Device in BostonThe company will showcase its DARE-IDDS platform during the upcoming PODD 2026 conference on October 30.
October 26, 2026
Jury Awards Former MIT Professor $6 Million in LawsuitA Boston jury ruled in favor of the former professor after rejecting counterclaims of harassment and retaliation.
More in Biotech
Regular subjects here include clinical trial results, regulatory approvals for therapies, corporate mergers and the commercialization of genetic findings. It reaches across the city and the communities around it where research and development occur. The concentration of laboratory space and institutional partnerships in the area creates a distinct environment for rapid scientific innovation. High capital requirements and the length of the development cycle remain the most common constraints on new projects.